Accretion Pharmaceuticals Ltd Share Price

Pharmaceuticals

NSE: ACCPL Small Cap ISIN: INE0T8T01010

As on 13 June 2026 at 02:26 IST

Stock Not Traded in NSE

Over 1 Month

10.31%

Over 6 Months

46.51%

Over 1 Year

70.62%

Over 3 Years

None%

Accretion Pharmaceuticals Ltd Summary

Close ₹135.30

Open ₹139.20

High ₹140

Low ₹135.30

Volume 14,400

Net Turnover (in Cr) ₹0.19

52Wk High -

52Wk Low -

52Wk High / Low

Accretion Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹150.40

EPS (TTM) 8.70

Book Value (BV) 49.21

Div. Yield -

P/E (TTM) 15.55

Price/Book Value 2.75

Delivery % 100 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio -

EV to Sales -

PEG Ratio -

ROA 23.10

ROE 65.35

Debt-Equity 1.33

Net Profit Margin 11.83

Operating Profit Margin 20.88

Accretion Pharmaceuticals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Total Revenue	57.47	13.41
Total Expenses	47.71	11.41
Profit Before Tax	9.76	2
Profit After Tax	6.79	1.49
Operating Profit After Depreciation	11.20	2.39

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Fixed Assets	6.09	5.25
Total Non Current Assets	6.33	5.39
Total Current Assets	33.55	22.05
Total Assets	39.87	27.44
Total Shareholder's Fund	15.29	5.49

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Net Cash From Operating Activities	5.75	-11.51
Net Cash Used In Investing Activities	-1.61	-5.48
Net Cash Used In Financing Activities	-4.18	17.08

No data available

Accretion Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 133.73

S2 132.17

S3 129.03

Pivot 136.87

R1 138.43

R2 141.57

R3 143.13

Moving Average

20 SMA 125.90

50 SMA 105.48

100 SMA 86.92

200 SMA 78.43

Accretion Pharmaceuticals Ltd Corporate Actions

No available data

Accretion Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Accretion Pharmaceuticals Ltd Top Mutal Funds Invested

No data available

Accretion Pharmaceuticals Ltd News

Accretion Pharmaceuticals announces board meeting date

On 8 May 2026

02 May 2026, 12:25 pm

Accretion Pharmaceuticals to table results

On 14 November 2025

10 Nov 2025, 01:38 pm

Accretion Pharmaceuticals to convene AGM

On 25 September 2025

04 Sep 2025, 06:12 pm

Accretion Pharmaceuticals Ltd Stock Analysis

Annual revenue for Accretion Pharmaceuticals Ltd increased by 328.65% to ₹57.47 crore in FY 2025 from ₹13.41 crore in FY 2024.
Annual Net Profit for Accretion Pharmaceuticals Ltd increased by 355.08% to ₹6.79 crore in FY 2025 from ₹1.49 crore in FY 2024.
Promoter Shareholding in Accretion Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 73.52% in December 2025 to 73.52% in March 2026.
Accretion Pharmaceuticals Ltd delivered a 1-year return of 70.62% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Accretion Pharmaceuticals Ltd share price moved down by 100.00% from its previous close of INR ₹135.30. The latest Accretion Pharmaceuticals Ltd share price is INR ₹0.
Accretion Pharmaceuticals Ltd share price today has been at a low of 135.30 and a high of 140. Over the past 52 weeks, the Accretion Pharmaceuticals Ltd share price has seen a low of 53.80 and a high of 145.85.